OpenFilings

Theravance Biopharma, Inc.

Form10-K

Report Period2024-12-31

Date Filed2025-03-07

Time Filed06:15:33

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
EX-10.19
EX-19
EX-21.1
EX-23.1
EX-31.1
EX-31.2
EX-32
Filing on SEC Edgar